Straumann, a major Swiss dental implant manufacturer, announced revenue of $3.4 billion for 2025, surpassing analyst predictions. The company is projecting high single-digit growth through 2026, driven by strong performance in European markets.
A leading Swiss dental implant manufacturer announced Wednesday that it exceeded revenue projections for 2025 and outlined ambitious growth plans extending to 2026.
Straumann reported annual revenue of 2.61 billion Swiss francs, equivalent to approximately $3.4 billion, which topped analyst forecasts of 2.59 billion francs according to Vara consensus data.
The dental technology company achieved organic sales expansion of 8.9% for the full year, slightly outperforming market expectations. Company officials attributed this success primarily to robust results across European markets.
Looking ahead, Straumann projects revenue growth in the high single-digit percentage range through 2026. The company highlighted strong results in North American markets and the Asia Pacific region, though it noted China as an exception due to softer patient volumes ahead of upcoming procurement changes.
China’s implementation of a new volume-based procurement system has significantly reduced implant costs for consumers, leading to increased demand in that market.
Company CEO Guillaume Daniellot praised the year’s achievements in an official statement: “2025 was a year of strong performance and execution for all of us… We continued to gain additional market share and delivered robust growth.”
The currency conversion rate used was $1 equals 0.7707 Swiss francs.
More from TV Delmarva Channel 33 News